Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.
about
P2860
Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@en
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@nl
type
label
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@en
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@nl
prefLabel
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@en
Dysbindin as a novel biomarker ...... tified by proteomic profiling.
@nl
P2093
P2860
P356
P1476
Dysbindin as a novel biomarker ...... ntified by proteomic profiling
@en
P2093
Cheng Fang
Dongmei Wang
Fengsong Wang
Xiaohui Lv
Xuebiao Yao
P2860
P304
P356
10.1002/IJC.30227
P50
P577
2016-06-30T00:00:00Z